IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-51182-3.html
   My bibliography  Save this article

Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice

Author

Listed:
  • Ling Huang

    (Wuhan Institute of Virology, Chinese Academy of Sciences
    Wuhan Institute of Virology, Chinese Academy of Sciences
    University of Chinese Academy of Sciences)

  • Wei Tang

    (Wuhan Institute of Virology, Chinese Academy of Sciences)

  • Lina He

    (Wuhan Institute of Virology, Chinese Academy of Sciences
    Wuhan Institute of Virology, Chinese Academy of Sciences)

  • Mengke Li

    (Wuhan Institute of Virology, Chinese Academy of Sciences)

  • Xian Lin

    (Wuhan Institute of Virology, Chinese Academy of Sciences
    Wuhan Institute of Virology, Chinese Academy of Sciences
    Hubei JiangXia Laboratory)

  • Ao Hu

    (Wuhan Institute of Virology, Chinese Academy of Sciences)

  • Xindi Huang

    (Wuhan Institute of Virology, Chinese Academy of Sciences
    Wuhan Institute of Virology, Chinese Academy of Sciences)

  • Zhouyu Wu

    (Wuhan Institute of Virology, Chinese Academy of Sciences
    University of Chinese Academy of Sciences)

  • Zhiyong Wu

    (Wuhan Institute of Virology, Chinese Academy of Sciences
    University of Chinese Academy of Sciences)

  • Shiyun Chen

    (Wuhan Institute of Virology, Chinese Academy of Sciences)

  • Yangbo Hu

    (Wuhan Institute of Virology, Chinese Academy of Sciences
    Wuhan Institute of Virology, Chinese Academy of Sciences
    Hubei JiangXia Laboratory)

Abstract

Influenza virus infection remains a major global health problem and requires a universal vaccine with broad protection against different subtypes as well as a rapid-response vaccine to provide immediate protection in the event of an epidemic outbreak. Here, we show that intranasal administration of probiotic Escherichia coli Nissle 1917 activates innate immunity in the respiratory tract and provides immediate protection against influenza virus infection within 1 day. Based on this vehicle, a recombinant strain is engineered to express and secret five tandem repeats of the extracellular domain of matrix protein 2 from different influenza virus subtypes. Intranasal vaccination with this strain induces durable humoral and mucosal responses in the respiratory tract, and provides broad protection against the lethal challenge of divergent influenza viruses in female BALB/c mice. Our findings highlight a promising delivery platform for developing mucosal vaccines that provide immediate and sustained protection against respiratory pathogens.

Suggested Citation

  • Ling Huang & Wei Tang & Lina He & Mengke Li & Xian Lin & Ao Hu & Xindi Huang & Zhouyu Wu & Zhiyong Wu & Shiyun Chen & Yangbo Hu, 2024. "Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51182-3
    DOI: 10.1038/s41467-024-51182-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-51182-3
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-51182-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Fernando P. Canale & Camilla Basso & Gaia Antonini & Michela Perotti & Ning Li & Anna Sokolovska & Julia Neumann & Michael J. James & Stefania Geiger & Wenjie Jin & Jean-Philippe Theurillat & Kip A. W, 2021. "Metabolic modulation of tumours with engineered bacteria for immunotherapy," Nature, Nature, vol. 598(7882), pages 662-666, October.
    2. Lei Deng & Teena Mohan & Timothy Z. Chang & Gilbert X. Gonzalez & Ye Wang & Young-Man Kwon & Sang-Moo Kang & Richard W. Compans & Julie A. Champion & Bao-Zhong Wang, 2018. "Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses," Nature Communications, Nature, vol. 9(1), pages 1-12, December.
    3. Daniel S. Leventhal & Anna Sokolovska & Ning Li & Christopher Plescia & Starsha A. Kolodziej & Carey W. Gallant & Rudy Christmas & Jian-Rong Gao & Michael J. James & Andres Abin-Fuentes & Munira Momin, 2020. "Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity," Nature Communications, Nature, vol. 11(1), pages 1-15, December.
    4. Jenna J. Guthmiller & Julianna Han & Henry A. Utset & Lei Li & Linda Yu-Ling Lan & Carole Henry & Christopher T. Stamper & Meagan McMahon & George O’Dell & Monica L. Fernández-Quintero & Alec W. Freyn, 2022. "Broadly neutralizing antibodies target a haemagglutinin anchor epitope," Nature, Nature, vol. 602(7896), pages 314-320, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mairead K. Heavey & Anthony Hazelton & Yuyan Wang & Mitzy Garner & Aaron C. Anselmo & Janelle C. Arthur & Juliane Nguyen, 2024. "Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    2. Kemin Tan & Junjian Chen & Yu Kaku & Yi Wang & Luke Donius & Rafiq Ahmad Khan & Xiaolong Li & Hannah Richter & Michael S. Seaman & Thomas Walz & Wonmuk Hwang & Ellis L. Reinherz & Mikyung Kim, 2023. "Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    3. Jae Sung Cho & Dongsoo Yang & Cindy Pricilia Surya Prabowo & Mohammad Rifqi Ghiffary & Taehee Han & Kyeong Rok Choi & Cheon Woo Moon & Hengrui Zhou & Jae Yong Ryu & Hyun Uk Kim & Sang Yup Lee, 2023. "Targeted and high-throughput gene knockdown in diverse bacteria using synthetic sRNAs," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    4. Jun Zhou & Maoyi Li & Qiufang Chen & Xinjie Li & Linfu Chen & Ziliang Dong & Wenjun Zhu & Yang Yang & Zhuang Liu & Qian Chen, 2022. "Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    5. Daniëla Maria Hinke & Ane Marie Anderson & Kirankumar Katta & Marlene Fyrstenberg Laursen & Demo Yemane Tesfaye & Ina Charlotta Werninghaus & Davide Angeletti & Gunnveig Grødeland & Bjarne Bogen & Ran, 2024. "Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    6. Jung Hun Park & Gábor Holló & Yolanda Schaerli, 2024. "From resonance to chaos by modulating spatiotemporal patterns through a synthetic optogenetic oscillator," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
    7. Mohamad H. Abedi & Michael S. Yao & David R. Mittelstein & Avinoam Bar-Zion & Margaret B. Swift & Audrey Lee-Gosselin & Pierina Barturen-Larrea & Marjorie T. Buss & Mikhail G. Shapiro, 2022. "Ultrasound-controllable engineered bacteria for cancer immunotherapy," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    8. Dinh-Huy Nguyen & Ari Chong & Yeongjin Hong & Jung-Joon Min, 2023. "Bioengineering of bacteria for cancer immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-5, December.
    9. Yi Zhang & Mingjie Wang & Ling Ye & Shengqi Shen & Yuxi Zhang & Xiaoyu Qian & Tong Zhang & Mengqiu Yuan & Zijian Ye & Jin Cai & Xiang Meng & Shiqiao Qiu & Shengzhi Liu & Rui Liu & Weidong Jia & Xianzh, 2024. "HKDC1 promotes tumor immune evasion in hepatocellular carcinoma by coupling cytoskeleton to STAT1 activation and PD-L1 expression," Nature Communications, Nature, vol. 15(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51182-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.